David CFA - Acadia Healthcare Chief Officer
| ACHC Stock | USD 66.79 0.44 0.66% |
Insider
David CFA is Chief Officer of Acadia Healthcare
| Address | 6100 Tower Circle, Franklin, TN, United States, 37067 |
| Phone | 615 861 6000 |
| Web | https://www.acadiahealthcare.com |
Acadia Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.062 % which means that it generated a profit of $0.062 on every $100 spent on assets. This is way below average. Acadia Healthcare's management efficiency ratios could be used to measure how well Acadia Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.0067. In addition to that, Return On Capital Employed is expected to decline to 0.06. At present, Acadia Healthcare's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 50.9 M, whereas Total Assets are forecasted to decline to about 4.4 B.Similar Executives
| Showing other executives | INSIDER Age | ||
| Dawn Rock | Encompass Health Corp | N/A | |
| Patricia Maryland | Encompass Health Corp | 67 | |
| RN MHA | InnovAge Holding Corp | 62 | |
| John Winstel | DaVita HealthCare Partners | 53 | |
| L Shaw | Encompass Health Corp | 75 | |
| Anne Motsenbocker | US Physicalrapy | 59 | |
| Rusty Yeager | Encompass Health Corp | N/A | |
| Hugh Johnston | HCA Holdings | 59 | |
| Anthony Hernandez | Encompass Health Corp | 58 | |
| Jennifer Berres | HCA Holdings | 53 | |
| Adam Holton | Amedisys | 53 | |
| Maria Lozzano | InnovAge Holding Corp | 44 | |
| Dan Peoples | Enhabit | N/A | |
| Shawn Guertin | DaVita HealthCare Partners | 56 | |
| Mike Bavaro | Option Care Health | N/A | |
| BS MA | Enhabit | 56 | |
| Olivia Patton | InnovAge Holding Corp | N/A | |
| Ryan Kubota | InnovAge Holding Corp | N/A | |
| PT MBA | US Physicalrapy | 60 | |
| Clint Hailey | Tenet Healthcare | 59 | |
| Jennifer Griffin | Amedisys | N/A | |
Management Performance
| Return On Equity | -0.0012 | ||||
| Return On Asset | 0.062 |
Acadia Healthcare Leadership Team
Elected by the shareholders, the Acadia Healthcare's board of directors comprises two types of representatives: Acadia Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acadia. The board's role is to monitor Acadia Healthcare's management team and ensure that shareholders' interests are well served. Acadia Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acadia Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Laura Groschen, Chief Officer | ||
| Heather CPA, Chief Officer | ||
| Christopher Howard, Executive Vice President General Counsel, Secretary | ||
| Laurence Harrod, Ex Fin | ||
| David Duckworth, CFO, Chief Accounting Officer and Controller | ||
| Mark Palmenter, Chief Officer | ||
| Isa Diaz, Senior Affairs | ||
| Andrew Honeybone, VP Officer | ||
| David CFA, Chief Officer | ||
| Bill Priest, Chief Officer | ||
| Nasser MD, Operations Business | ||
| Christopher Hunter, CEO Director | ||
| Gretchen Hommrich, Vice Relations | ||
| John Hollinsworth, Executive Vice President of Operations | ||
| Brian Farley, General VP | ||
| MD JD, Chief Officer |
Acadia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Acadia Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0012 | ||||
| Return On Asset | 0.062 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 8.24 B | ||||
| Shares Outstanding | 92.77 M | ||||
| Shares Owned By Insiders | 2.84 % | ||||
| Shares Owned By Institutions | 97.16 % | ||||
| Number Of Shares Shorted | 3.21 M | ||||
| Price To Earning | 25.67 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Acadia Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Acadia Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Acadia Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Acadia Healthcare Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acadia Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Acadia Stock refer to our How to Trade Acadia Stock guide.Note that the Acadia Healthcare information on this page should be used as a complementary analysis to other Acadia Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Acadia Stock analysis
When running Acadia Healthcare's price analysis, check to measure Acadia Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acadia Healthcare is operating at the current time. Most of Acadia Healthcare's value examination focuses on studying past and present price action to predict the probability of Acadia Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acadia Healthcare's price. Additionally, you may evaluate how the addition of Acadia Healthcare to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Acadia Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acadia Healthcare. If investors know Acadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acadia Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.153 | Earnings Share (0.13) | Revenue Per Share 32.79 | Quarterly Revenue Growth 0.091 | Return On Assets 0.062 |
The market value of Acadia Healthcare is measured differently than its book value, which is the value of Acadia that is recorded on the company's balance sheet. Investors also form their own opinion of Acadia Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Acadia Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acadia Healthcare's market value can be influenced by many factors that don't directly affect Acadia Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acadia Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acadia Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acadia Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.